Healthcare costs in relation to increased use of preoperative renal tumour biopsies
The budget impact analysis of routine preoperative RTBs in suspected renal cell carcinoma indicates net healthcare cost savings in cT1a and potentially for all cT1 tumours.
Authors
- Fanny Goude (ORCID: https://orcid.org/0000-0001-6575-7563)
- Sven Lundstam (ORCID: https://orcid.org/0000-0003-4543-3398)
- Andreas Rosenblad (ORCID: https://orcid.org/0000-0003-3691-8326)
- Börje Ljungberg (ORCID: https://orcid.org/0000-0002-4121-3753)
- Per‐Olof Lundgren (ORCID: https://orcid.org/0000-0001-7976-6962)
- Torsten Lauritsen (ORCID: https://orcid.org/0000-0001-6575-9542)
- Agnes Lind
- Susanna von Holst
- Bassam Mazin Hashim (ORCID: https://orcid.org/0009-0006-8775-9774)
- Matilda Hagman
Institutions
- Uppsala University (SE)
- Karolinska Institutet (SE)
- Region Västra Götaland (SE)
- Västmanlands sjukhus Västerås (SE)
- Stockholm Health Care Services (SE)
- Skåne University Hospital (SE)
- Mälardalen University (SE)
- University of Gothenburg (SE)
- Umeå University (SE)
Publication Details
- Journal
- Scandinavian Journal of Urology
- Published
- 2025-03-13
- DOI
- https://doi.org/10.2340/sju.v60.43194
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52